Follow us

Experience

Indivior plc

in connection with the Relationship Agreement and settlement reached with the Company’s largest shareholder, the activist investor Scopia Management

Parkinson's UK

on its acquisition of assets relating to the research, development, manufacture and marketing of glial-cell line-derived neurotrophic factor (GDNF), a potentially disease-modifying treatment for Parkinson's disease

SK Holdings

on its acquisition of Yposkesi, a French market leader in gene therapy and viral vector manufacturing

Pharmaceuticals and healthcare

Insight not hindsight

Life science notes blog

Find analysis of the latest legal developments relevant to the life sciences

Key contacts

Alan Montgomery photo

Alan Montgomery

Partner, Co-Head Pharmaceuticals, Co-Head of India Practice, London

Alan Montgomery
Chris Parker KC photo

Chris Parker KC

Partner, Co-Head Pharmaceuticals, London

Chris Parker KC
Natalie Bryce photo

Natalie Bryce

Partner, Brisbane

Natalie Bryce